You are here: Industry Insights > Drug Price

News List

CMA launches COVID-19 taskforce to combat drug price hikes europeanpharmaceuticalreview
March 25, 2020
In the UK, the CMA has announced it will establish a taskforce to handle businesses that exploit the COVID-19 outbreak and inflate drug prices.
US group says Novartis MS drug price out of line with benefit expressbpd
June 27, 2019
The Boston-based Institute for Clinical and Economic Review (ICER), which has been reviewing Mayzent for months, recommended that Novartis lower the drug’s price
Pharma stocks fall after new drug price probe in US pharmaphorum
January 16, 2019
US politicians from the resurgent Democratic party have launched a probe into “unsustainable” drug price rises, prompting their shares to drop suddenly.
House Oversight Committee Launches Drug Price Investigation americanpharmaceuticalreview
January 16, 2019
Rep. Elijah E. Cummings (D-MD 7th District), the Chairman of the Committee on Oversight and Reform, launched an investigation into the prescription drug industry’s pricing practices....
Trump summons advisers to White House over drug price hikes firstwordpharma
January 10, 2019
According to sources, US President Donald Trump is meeting with top officials to discuss the latest round of drug price increases, Politico reported.
Pfizer plans 41 price hikes for January fiercepharma
November 26, 2018
Pfizer, which became the center of a drug pricing controversy this summer featuring President Donald Trump, has decided it’s ready to raise prices in early 2019.
Lawmakers field bill tying U.S. drug prices to prices abroad fiercepharma
November 26, 2018
Sen. Bernie Sanders, I-Vt., has spent years railing at the pharma industry, touting a series of proposals to control costs—each typically opposed by the industry.
Want to save $2.8B-plus? Medicare drug price negotiation could, senator reports fiercepharma
August 03, 2018
Federal law doesn’t allow Medicare to directly negotiate drug prices with pharmas. What if it did? A recent report from a U.S. senator found that Medicare bargaining could save Medicare Part D $2.8 billion a year on just the 20 most commonly prescribed br
No, Massachusetts, you can't run a PBM-style Medicaid formulary, feds say fiercepharma
July 04, 2018
As drug pricing moves at the federal level have floundered, state officials have taken matters into their own hands. But Massachusetts is discovering there's a limit to drug-pricing innovation.
Pfizer wins appeal against CMA fine over epilepsy drug price pharmaceutical-technology
June 13, 2018
US pharmaceutical giant Pfizer has won its appeal in the UK’s Competition Appeals Tribunal (CAT) against a £84.2m fine imposed by the Competition and Markets Authority (CMA) for dramatically increasing the price of its epilepsy drug, Epanutin.